All times are listed in CEST (Central European Summer Time)

Browsing Over 54 Sessions

Sort By
View
South Hall 2 Wed, 30.03.2022 11:30 - 13:00

Amgen - Targeting KRASG12C: A new era for patients with advanced NSCLC (ID 33)

Time
11:30 - 13:00
Location
South Hall 2
Date
Wed, 30.03.2022
Forum Hall Wed, 30.03.2022 11:30 - 13:00

Mirati Therapeutics, Inc. - Tailoring therapy: Emerging treatment options in NSCLC (ID 32)

Time
11:30 - 13:00
Location
Forum Hall
Date
Wed, 30.03.2022
Keynote lecture Congress Hall Congress Hall

Heine Hansen Award ELCC 2022 (ID 1)

Date
Wed, 30.03.2022
Time
13:45 - 14:15
Location
Congress Hall
Educational session South Hall 2 South Hall 2

Implementation of screening programs in Europe (ID 4)

Date
Wed, 30.03.2022
Time
14:30 - 16:00
Location
South Hall 2
Multidisciplinary Tumour Board Congress Hall Congress Hall

What to do after immunotherapy failure and when to avoid immunotherapy in early disease NSCLC (ID 2)

Date
Wed, 30.03.2022
Time
14:30 - 16:00
Chairs
  • Roy S. Herbst, New heaven, US
Location
Congress Hall
Educational session Forum Hall Forum Hall

Not so small anymore: New therapies and cutting-edge science to guide the care of patients with small cell lung cancer (ID 3)

Date
Wed, 30.03.2022
Time
14:30 - 16:00
Chairs
  • Jarushka Naidoo, Dublin, IE
Location
Forum Hall
Proffered Paper session Forum Hall Forum Hall

Proffered Paper session 1 (ID 43)

Date
Wed, 30.03.2022
Time
16:30 - 18:00
Location
Forum Hall
Educational session South Hall 2 South Hall 2

New insights in the treatment of geriatric patients (ID 6)

Date
Wed, 30.03.2022
Time
16:30 - 18:00
Chairs
  • Lore Decoster, Jette, BE
Location
South Hall 2
Educational session Congress Hall Congress Hall

Thymic tumours (ID 5)

Date
Wed, 30.03.2022
Time
16:30 - 18:00
Chairs
  • Enrico Ruffini, Torino, IT
  • Nicolas Girard, Paris, FR
Location
Congress Hall
Forum Hall Wed, 30.03.2022 18:15 - 19:45

Bristol Myers Squibb - Breaking barriers in thoracic cancers: The expanding possibilities for patients with I-O treatment (ID 34)

Time
18:15 - 19:45
Location
Forum Hall
Date
Wed, 30.03.2022
South Hall 2 Wed, 30.03.2022 18:15 - 19:45

Takeda - Novel therapies for EGFR exon 20 insertions and ALK-positive NSCLC: Developments and implications (ID 35)

Time
18:15 - 19:45
Location
South Hall 2
Date
Wed, 30.03.2022
Young oncologists session South Hall 2 South Hall 2

YO session 1 (ID 56)

Date
Thu, 31.03.2022
Time
08:00 - 09:00
Location
South Hall 2